GL1X · GenesisL1 explorer

MolNFT v1 · #89119 · protein

Inhibition of an antibiotic resistance enzyme: crystal structure of aminoglycoside phosphotransferase APH(2")-ID/APH(2")-iva in complex with kanamycin inhibited with quercetin

4DFU: “Inhibition of an antibiotic resistance enzyme: crystal structure of aminoglycoside phosphotransferase…”. X-ray diffraction, 3 ligands (QUE, KAN, CL), 12 pockets (best druggability 0.80). MolNFT v1 #89119 on GenesisL1: 3D structure…

PDB
4DFU
Type
protein
Length
593 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
APH(2")-id
UniProt
O68183
Ligands
QUE, KAN, CL
Pockets
12 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAPH(2")-idprotein29647% helix, 15% strandO68183
BAPH(2")-idprotein29747% helix, 15% strandO68183

Ligands and binding sites

  • QUE · 3,5,7,3',4'-pentahydroxyflavone · ligand · 3 copies · chains A, B
  • KAN · Kanamycin A · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13740.800.8958QUE
22360.760.9039empty
32160.660.8431QUE
41390.640.8730QUE
5560.560.8915empty

Interfaces

1 interface between chains.

  • A–B · 1322 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 modified (engineered).

Compared structures

  • 4DFU · Inhibition of an antibiotic resistance enzyme: crystal structure of aminoglycoside… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.